Justin Petrone

The new strategy coincides with the launch of Genomics Data Infrastructure Ireland, a separate project for Irish genomic and clinical data.

Among many objectives, the project will perform whole-genome sequencing of 10,000 individuals to build out its reference genome set.

The initiative will expand on the expertise gained through the use of genomic sequencing during the ongoing COVID-19 pandemic, applying it to other respiratory pathogens.

The grant was recently awarded through the EU's Cancer Mission, a funding program to reduce cancer cases throughout the EU by 2030.

The project, called PCR-4-All, officially commenced Dec. 1 and will run through November 2026.

The UK government said it will also invest £26 million to support cancer genomics research, and an additional £22 million to improve genomic data diversity.

Among the objectives of the CGI-Clinics effort is to have a CE-IVD marked analysis tool available by the end of 2027.

The researchers, based in the UK and Estonia, also recently released a tool to factor genetic ancestry into polygenic score calculations.

The Danish rare cell diagnostics company is also in the process of migrating its tests from array comparative hybridization to next-generation sequencing.

CEO and Cofounder İbrahim Çağrı Kurt discussed the new test during a presentation at Slush, an annual startup conference held in Helsinki this week.